This compound, a 1,5-benzothiazepin-4(5H)-one derivative, acts as a weak inhibitor of GSK-3beta with an IC50 exceeding 100 µM. It serves as a useful research tool for investigating GSK-3beta signaling pathways in cellular models of neurological disorders and diabetes.
Molecular Weight:
283.39
Purity:
99.97% (May vary between batches)
CAS Number:
[863004-48-2]
Formula:
C17H17NOS
Target:
GSK-3
Application Notes:
Solubility: DMSO:2.88 mg/mL (10.16 mM)
* VAT and and shipping costs not included. Errors and price changes excepted